» Articles » PMID: 31554344

The Role of MiRNAs in Immune Cell Development, Immune Cell Activation, and Tumor Immunity: With a Focus on Macrophages and Natural Killer Cells

Overview
Journal Cells
Publisher MDPI
Date 2019 Sep 27
PMID 31554344
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment (TME) is the primary arena where tumor cells and the host immune system interact. Bidirectional communication between tumor cells and the associated stromal cell types within the TME influences disease initiation and progression, as well as tumor immunity. Macrophages and natural killer (NK) cells are crucial components of the stromal compartment and display either pro- or anti-tumor properties, depending on the expression of key regulators. MicroRNAs (miRNAs) are emerging as such regulators. They affect several immune cell functions closely related to tumor evasion of the immune system. This review discusses the role of miRNAs in the differentiation, maturation, and activation of immune cells as well as tumor immunity, focusing particularly on macrophages and NK cells.

Citing Articles

Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma.

Wang L, Liu X, Lv H, Zhang H, Lin R, Xu S Biology (Basel). 2025; 14(1).

PMID: 39857292 PMC: 11759184. DOI: 10.3390/biology14010061.


Comparison of miRNA cargo in human adipose-tissue . amniotic-membrane derived mesenchymal stromal cells extracellular vesicles for osteoarthritis treatment.

Ragni E, Perucca Orfei C, Papait A, de Girolamo L Extracell Vesicles Circ Nucl Acids. 2024; 2(3):202-221.

PMID: 39697592 PMC: 11648501. DOI: 10.20517/evcna.2021.11.


High efficiency protocol for platelet derived fibrin gel loaded with mesenchymal stromal cells extracellular vesicles.

Ragni E, De Luca P, Landoni S, Valli F, Mortati L, Palombella S Regen Ther. 2024; 26:442-457.

PMID: 39070124 PMC: 11276930. DOI: 10.1016/j.reth.2024.06.020.


Innovative Diagnosis and Therapeutic Modalities: Engineered Exosomes in Autoimmune Disease.

Ji Y, Mi L, Zhao M, He X, Hu Y, Gao Y Int J Nanomedicine. 2024; 19:3943-3956.

PMID: 38708179 PMC: 11070165. DOI: 10.2147/IJN.S452184.


Insight into microRNAs' involvement in hematopoiesis: current standing point of findings.

Nassiri S, Ahmadi Afshar N, Almasi P Stem Cell Res Ther. 2023; 14(1):282.

PMID: 37794439 PMC: 10552299. DOI: 10.1186/s13287-023-03504-3.


References
1.
Xie J, Liu M, Li Y, Nie Y, Mi Q, Zhao S . Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. Cell Mol Immunol. 2014; 11(5):495-502. PMC: 4197204. DOI: 10.1038/cmi.2014.30. View

2.
Mundy-Bosse B, Scoville S, Chen L, McConnell K, Mao H, Ahmed E . MicroRNA-29b mediates altered innate immune development in acute leukemia. J Clin Invest. 2016; 126(12):4404-4416. PMC: 5127669. DOI: 10.1172/JCI85413. View

3.
Wu J, Zhang X, Shi K, Chen Y, Ren Y, Song Y . Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells. Carcinogenesis. 2013; 35(1):155-63. DOI: 10.1093/carcin/bgt268. View

4.
Zhuang G, Meng C, Guo X, Cheruku P, Shi L, Xu H . A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation. 2012; 125(23):2892-903. DOI: 10.1161/CIRCULATIONAHA.111.087817. View

5.
Dolken L, Krmpotic A, Kothe S, Tuddenham L, Tanguy M, Marcinowski L . Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog. 2010; 6(10):e1001150. PMC: 2954898. DOI: 10.1371/journal.ppat.1001150. View